Evidence map›Paper›PMID 35008721›Full record

ArticleInternational journal of molecular sciences2021

Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations.

Mayara J Prado, Shripriya Singh, Rodrigo Ligabue-Braun, Bruna V Meneghetti, Thaiane Rispoli, Cristiane Kopacek, Karina Monteiro, Arnaldo Zaha, Maria L R Rossetti, Amit V Pandey

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Integrated mapping resolves pathogenicity of 11Journal of the Endocrine Society · 2026
    Article
  2. SomeJournal of clinical medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Mayara J PradoGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.ORCID 0000-0003-0647-4429
Shripriya SinghDepartment of Biomedical Research, University of Bern, 3010 Bern, Switzerland.
Rodrigo Ligabue-BraunDepartament of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre 90050-170, Brazil.ORCID 0000-0002-2555-9754
Bruna V MeneghettiGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.
Thaiane RispoliGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.ORCID 0000-0003-4421-8995
Cristiane KopacekServiço de Referência em Triagem Neonatal, Hospital Materno Infantil Presidente Vargas, Porto Alegre 90035-074, Brazil.
Karina MonteiroGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.
Arnaldo ZahaGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.
Maria L R RossettiGraduate Program in Cell and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.
Amit V PandeyDepartment of Biomedical Research, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0001-8331-5902
Universidade Federal do Rio Grande do Sul · BRUniversity of Bern · CHHospital Ernesto Dornelles · BRUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

Swiss Government Excellence Scholarship 2020.0176Swiss Government Excellence Scholarship 2020.0209
6 · The paper itself

Abstract

Deficiency of 21-hydroxylase enzyme (CYP21A2) represents 90% of cases in congenital adrenal hyperplasia (CAH), an autosomal recessive disease caused by defects in cortisol biosynthesis. Computational prediction and functional studies are often the only way to classify variants to understand the links to disease-causing effects. Here we investigated the pathogenicity of uncharacterized variants in the CYP21A2 gene reported in Brazilian and Portuguese populations. Physicochemical alterations, residue conservation, and effect on protein structure were accessed by computational analysis. The enzymatic performance was obtained by functional assay with the wild-type and mutant CYP21A2 proteins expressed in HEK293 cells. Computational analysis showed that p.W202R, p.E352V, and p.R484L have severely impaired the protein structure, while p.P35L, p.L199P, and p.P433L have moderate effects. The p.W202R, p.E352V, p.P433L, and p.R484L variants showed residual 21OH activity consistent with the simple virilizing phenotype. The p.P35L and p.L199P variants showed partial 21OH efficiency associated with the non-classical phenotype. Additionally, p.W202R, p.E352V, and p.R484L also modified the protein expression level. We have determined how the selected CYP21A2 gene mutations affect the 21OH activity through structural and activity alteration contributing to the future diagnosis and management of CYP21A2 deficiency.

Indexed as

Genetics, PopulationAdolescentAmino Acid SequenceBrazilChild, PreschoolComputer SimulationConserved SequenceFemaleHumansInfantKineticsMaleModels, MolecularMutant ProteinsMutationPortugalCYP21A2 protein, humanMutant ProteinsSteroid 21-Hydroxylase21-hydroxylase deficiencycongenital adrenal hyperplasiaCYP21A2functional characterization

Identifiers

PMID35008721
PMCPMC8745212
OpenAlexW4200066472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.